2026-05-04 05:25:21
Latest Post
Energy in Motion Ltd commissions operations at Nhava Sheva Freeport Container Terminal
Prudent Corporate Advisory Services Ltd launches Edge+
IKIO Technologies Ltd Q4 FY2026 consolidated PAT rises to Rs. 16.48 crores
Mitsu Chem Plast Ltd recommends final dividend of Rs. 0.20
L G Balakrishnan & Bros Ltd recommends dividend of Rs. 22
Stock Report
Sudarshan Pharma Industries Ltd Q4FY26 consolidated profit increases to Rs. 10.72 crores
Posted On : 2026-05-03 10:24:38( TIMEZONE : IST )
Sudarshan Pharma Industries Limited has reported Consolidated financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 225.0463 crores during the period ended March 31, 2026 as compared to Rs. 169.5242 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 10.7262 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 4.3571 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 0.47 for the period ended March 31, 2026 as compared to Rs. 0.18 for the period ended December 31, 2025.
| Financials | Q4 FY2026 | Q3 FY2026 | % Change |
| Total Income | ₹ 225.0463 crs | ₹169.5242 crs |  32.75% |
| Net Profit | ₹10.7262 crs | ₹4.3571 crs | 146.18% |
| EPS | ₹0.47 | ₹0.18 | 161.11% |
Financial Results (Q4 FY2026) - YoY Comparison
The company has reported total income of Rs. 225.0463 crores during the period ended March 31, 2026 as compared to Rs.162.4332 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.10.7262 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.7.4136 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.0.47 for the period ended March 31, 2026 as compared to Rs.0.29 for the period ended March 31, 2025.
| Financials | Q4 FY2026 | Q4 FY2025 | % Change |
| Total Income | ₹ 225.0463 crs | ₹162.4332 crs | 38.55% |
| Net Profit | ₹10.7262 crs | ₹7.4136 crs | 44.68% |
| EPS | ₹0.47 | ₹0.29 | 62.07% |
Financial Results (Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.711.7695 crores during the Financial Year ended March 31, 2026 as compared to Rs.507.6903 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.23.3033 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.14.9675 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.0.97 for the Financial Year ended March 31, 2026 as compared to Rs.0.62 for the Financial Year ended March 31, 2025.
| Financials | Year Ended FY2026 | Year Ended FY2025 | % Change |
| Total Income | ₹711.7695 crs | ₹507.6903 crs | 40.20% |
| Net Profit | ₹23.3033 crs | ₹14.9675 crs | 55.69% |
| EPS | ₹0.97 | ₹0.62 | 56.45% |
Shares of Sudarshan Pharma Industries Limited was last trading in BSE at Rs. 30.00 as compared to the previous close of Rs. 30.00. The total number of shares traded during the day was 12000 in over 3 trades.
The stock hit an intraday high of Rs. 30.99 and intraday low of 30.00. The net turnover during the day was Rs. 363960.00.
